Explore Products

AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19

  • AcceGen R&D Team
  • Jul 29, 2021
  • 18

You Might Also Like

AcceGen Scroll Top Button